Analysis of genomic breakpoints in p190 and p210 BCR-ABL indicate distinct mechanisms of formation.
Score J, Calasanz MJ, Ottman O, Pane F, Yeh RF, Sobrinho-Simões MA, Kreil S, Ward D, Hidalgo-Curtis C, Melo JV, Wiemels J, Nadel B, Cross NC, Grand FH.
Score J, et al. Among authors: nadel b.
Leukemia. 2010 Oct;24(10):1742-50. doi: 10.1038/leu.2010.174. Epub 2010 Aug 12.
Leukemia. 2010.
PMID: 20703256
Clinical Trial.